|
Could this
mean an end to Cataract Surgery?
A revolutionary new
treatment for cataracts has been gaining in popularity here in Europe
since it was featured over in the UK on the Richard & Judy Television
Show last year with amazing results. Ethos GmbH Schweiz, the Swiss
manufacturers, claim 'This could mean an end to cataract surgery'. The
product, called Ethos Endymion "Bright Eyes", uses a special derivative of
the naturally occurring neuropeptide L-Carnosine, called
N-Acetyl-Carnosine (NAC), which is a super antioxidant and anti-glycating
agent. NAC, when topically applied, can penetrate and protect the lipid
tissues of the eye against light damage and also helps to diminish free
radical damage and the harmful effects of glycosylation associated with
degenerative eye disease.
Cataract is a major problem globally;
17 million people around the world are blind because of cataracts
and 28,000 new cases are reported every day. Approximately 25% of the
population over 65 (and about 50% over 80) have a serious loss of vision
due to cataracts. At any one time in the UK alone there are over 500,000
people awaiting cataract surgery and the figures for the rest of Europe
are frightening. One leading London Hospital over in the UK carries out
between 250 and 500 cataract operations a week! The backlog is proving to
be such a big problem for them that now, Cataract Units are being drafted
in from abroad to help to address their very worrying
situation.
Professor Steven Charles Gallant, the world renowned biochemist who was
originally responsible for introducing Bright Eyes to Europe says; "I have
been studying the effects of L-Carnosine for many years. It was first
discovered back in 1988 that N-Acetyl-Carnosine had positive effects on
cataracts. My father had cataracts and did not relish going under the
knife so I tried to get some for him but unfortunately, at the time, it
wasn't easily obtainable. My father had to have the operation, which
thankfully was successful. But that got me to thinking how great it would
be if we were to develop, and make readily available, a product whereby
this condition could be addressed with a simple course of eye drops as
opposed to invasive surgery. After many years' research, development
and trials of Bright Eyes, many people are now enjoying much-improved
vision due to this exciting medical breakthrough."
One of the
clinical trials carried out in China, on 96 patients with cataracts of
varying degrees of severity, showed a profound effect; with the effective
rate being 100% on primary senile cataract and 80% for mature senile
cataract over the 6 month trial period. Positive effects were also
observed with other types of cataract. Another trial indicated an eye
condition improvement of 41.5% to 100% for patients within a 6-month
period, with sustainable results 24-months later.
A box of Bright
Eyes costs 100 Swiss francs (approximately £50, €75 or $100) and contains
5 x 2ml vials which is roughly a month's supply when using two drops a day
in each eye. With the majority of people seeing positive results over a
3-6 month period, it is a relatively inexpensive course of treatment when
you consider that a cataract operation costs over 4,000 Swiss francs
(approximately £2,000, €3,000 or $3,500) for one eye, and over 7,500 Swiss
francs (approximately £3,500, €5,000 or $6,500) for both.

|